Leading edge cybersecurity starts with a vision – and Amgen, a worldwide pioneer in biotechnology, has developed and socialized a clear and compelling vision for its security future.
The ICS/OT community attracted high-profile attention in 2022. Headlines around the world highlighted the motivation for targeting ICS/OT and underscored the impact of disruption beyond a business and into the community it serves.
Threat intelligence consumers must realize the limitations faced by producers and formulate their own analysis and integration of third-party threat intelligence to incorporate other sources to fill in gaps where possible.
Download this report and learn how:
Malware-exclusive analysis may miss vital aspects of a...
Our website uses cookies. Cookies enable us to provide the best experience possible and help us understand how visitors use our website. By browsing inforisktoday.com, you agree to our use of cookies.
